Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice

Brain Research

Volumn 752, Issue 1-2, 1997, Pages 61-71

  Reddy, D S ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

anxiety; GABA A receptor; mirrored chamber; motor activity; neurosteroid; progesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ANXIOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIZOCILPINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROSTEROID; NIFEDIPINE; PICROTOXIN; PRASTERONE; PREGNENOLONE; PROGESTERONE; TRIAZOLAM;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUMAZENIL; GABA ANTAGONISTS; GABA MODULATORS; ISOQUINOLINES; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; NIFEDIPINE; PICROTOXIN; REACTION TIME; STEROIDS; TRIAZOLAM;

EID: 0030896347     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01447-3     Document Type: Article

References (57)

1. Auta, J., Romeo, E., Kozikowski, A., Ma, D., Costa, E. and Guidotti, A., Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives, J. Pharmacol Exp. Ther., 265 (1993) 9649-9656.
2. Belelli, D., Bolger, M.B. and Gee, K.W., Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one, Eur. J. Pharmacol., 166 (1989) 125-329.
3. Bitran, D., Hilvers, R.J. and Kellogg, C.K., Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABA-A receptor, Brain Res., 561 (1991) 157-161.
4. Bitran, D., McLeod, M. and Shiekh, M., Blockade of the bioconversion of progesterone to allopregnanolone prevents the anxiolytic effect and potentiation of cortical GABA-A receptor function observed in progesterone-treated overiectomized rats, Soc. Neurosc. Abstr., 19 (1993) 373-373.
5. Bitran, D., Purdy, R.H. and Kellogg, C.K., Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABA-A receptor function, Pharmacol. Biochem. Behav., 45 (1993) 423-428.
6. Bitran, D., Shiekh, M. and McLeod, M., Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABA-A receptors, J. Neuroendocrinol., 7 (1995) 171-177.
7. Bowers, B.J. and Wehner, J.M., Biochemical and behavioral effects of steroids on GABA-A receptor function in long- and short-sleep mice, Brain Res. Bull., 29 (1992) 57-68.
8. Bowlby, M.R., Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons, Mol. Pharmacol., 43 (1993) 813-819.
9. Crawley, J.N., Glowa, J.R., Majewska, M.D. and Paul, S.M., Anxiolytic activity of an endogenous adrenal steroid, Brain Res., 398 (1986) 382-385.
10. Demirgoren, S., Majewska, M.D., Spivak, C.E. and London, E.D., Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABA-A receptor, Neuroscience, 45 (1991) 127-135.
11. Dennerstein, L., Spencer-Gardner, C., Gottis, G., Brown, J.B., Smith, M.A. and Burrows, G.D. Progesterone and the premenstrual syndrome: a double blind crossover trial, Br. Med. J., 290 (1985) 1617-1621.
12. Deutsch, S.I., Mastropaolo, J. and Hitri, A., GABA-active steroids: endogenous modulators of GABA-gated chloride ion conductance, Clin. Neuropharmacol., 15 (1992) 352-364.
13. Fernandez-Guasti, A. and Picazo, O., Changes in burying behavior during the estrous cycle: effect of estrogen and progesterone, Psychoneuroendocrinology, 17 (1992) 681-689.
14. Ffrench-Mullen, J.M.H., Danks, P. and Spence, K.T., Neurosteroids modulate calcium currents in hippocampal CA1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism, J. Neurosci., 14 (1994) 1963-1977.
15. Finn, D.A. and Gee, K.W., The influence of estrus cycle on neurosteroid potency at the gamma-aminobutyric acid A receptor complex, J. Pharmacol Exp. Ther., 265 (1993) 1374-1379.
16. Frye, C.A., The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy, Brain Res., 696 (1995) 113-120.
17. Gallup Jr., G.G., Mirror-image stimulation, Psychol. Bull., 70 (1968) 782-793.
18. Gee, K.W., Bolger, MB., Brinton, R.E., Coirini, H. and McEven, B.S., Steroid modulation of the chloride ionophore in rat brain: structure activity requirements, regional dependence and mechanism of action, J. Pharmacol. Exp. Ther., 246 (1988) 803-812.
19. Gee, K.W., McCauley, L.D. and Lan, N.C., A putative receptor for neurosteroids on the GABA-A receptor complex: the pharmacological properties and therapeutic potential of epalons, Crit. Rec. Neurobiol., 9 (1995) 207-227.
20. 3H]muscimol binding to the GABA-A receptor complex in rat cortex, Eur. J. Pharmacol., 288 (1995) 157-162.
21. Hawkinson, I.E., Kimbrough, C.L., McCauley, L.D., Bolger, M.B., Lan, N.C. and Gee, K.W., The neuroactive steroid 3α-hydroxy-5β-pregnan-20-one is a two-component modulator of ligand binding to the GABA-A receptor, Eur. J. Pharmacol., 269 (1994) 157-163.
22. Kavaliers, M., Inhibitory influences of the adrenal steroid 3α,5α-tetrahydroxycorticosterone, on aggression and defeat-induced analgesia in mice, Psychopharmacology, 95 (1988) 488-492.
23. Kirac, R. and Eroglu, L., Bay K-8644 potentiates the anxiolytic effect of ethanol, Pharmacol. Biochem. Behav., 39 (1991) 30-34.
24. Kokate, T.G., Svensson, B.E. and Rogawski, M.A., Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation, J. Pharmacol. Exp. Ther., 279 (1994) 1223-1229.
25. Korneyev, A., Pan, B.S., Polo, A., Romeo, E., Guidotti, A. and Costa, E., Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo, J. Neurochem., 61 (1993) 1515-1524.
26. Kulkarni, S.K. and Reddy, D.S., Animal behavioral models for testing antianxiety agents, Methods Find. Exp. Clin. Pharmacol., 18 (1996) 219-230.
27. Kulkarni, S.K. and Reddy, D.S., Neurosteroids: a new class of neuromodulators, Drugs Today / Med. Actual., 31 (1995) 433-455.
28. Lambert, J.J., Belelli, D., Hill-Venning, C. and Peters, J.A., Neurosteroids and GABA-A receptor function, Trends Pharmacol. Sci., 16 (1995) 295-303.
29. Lan, N., Chen, J.S., Belelli, D., Pritchett, D., Seeburg, P.H. and Gee, K.W., A steroid recognition site is functionally coupled to an expressed GABA-A/benzodiazepine receptor, Eur. J. Pharmacol., 188 (1990) 403-406.
30. Lan, N.C. and Gee, K.W., Neuroactive steroid actions at the GABA-A receptor, Horm. Behav., 28 (1994) 537-544.
31. Majewska, M.D. and Schwartz, R.D., Pregnenolone-sulfate: an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain?. Brain Res., 404 (1987) 355-360.
32. Majewska, M.D., Bluet-Pajot, M.T., Robel, P. and Baulieu, E.E., Pregnenolone sulfate antagonizes barbiturate-induced sleep, Pharmacol. Biochem. Behav., 33 (1989) 701-703.
33. Majewska, M.D., Neurosteroids: endogenous bimodal modulators of the GABA-A receptor. Mechanism of action and physiological significance, Prog. Neurobiol., 38 (1992) 379-395.
34. Melchior, C.L. and Allen, P.M., Interaction of prenenolone sulfate with ethanol and pentobarbital, Pharmacol. Biochem. Behav., 42 (1992) 605-611.
35. Melchior, C.L. and Ritzmann, R.F., Dehydroepiandrosterone is an anxiolytic in mice on the plus-maze. Pharmacol. Biochem. Behav., 47 (1994) 437-441.
36. Melchior, C.L. and Ritzmann, R.F., Pregnenolone and pregnenolone sulfate, alone and with ethanol, in mice on the plus-maze, Pharmacol. Biochem. Behav., 48 (1994) 893-897.
37. Melchior, C.L., Glasky, A. and Ritzmann, R.F., Dehydroepiandrosterone (DHEA) improves memory in normal mice and mice with age-induced memory deficits, Soc. Neurosci. Abstr., 18 (1992) 1660.
38. Mienville, J.M. and Vicini, S., Pregnenolone sulfate antagonizes GABA-A receptor-mediated currents via a reduction of channel opening frequency, Brain Res., 489 (1989) 190-194.
39. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus, Proc. Natl. Acad. Sci. USA, 92 (1995) 3774-3778.
40. Nasman, B., Olsson, T., Backstrom, T., Eriksson, S., Grankvist, K., Viitanen, M. and Bucht, G., Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia, Biol. Psychiatry, 30 (1991) 684-690.
41. Owens, M.J., Ritchie, J.C. and Nemerof, C.B., 5α-Pregnane-3α,21-diol-20-one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a non-glucocorticoid mechanism; comparison with alprazolam, Brain Res., 573 (1992) 353-355.
42. Papadopoulos, V., Guarneri, P., Krueger, K.E., Guidotti, A. and Costa, E., Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by mitochondrial diazepam binding inhibitor receptor, Proc. Natl. Acad. Sci. USA, 89 (1992) 45113-45117.
43. Picazo, O. and Fernandez-Guasti, A., Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test, Brain Res., 680 (1995) 135-141.
44. Pucilowski, O., Psychopharmacological properties of calcium channel inhibitors, Psychopharmacology (Berlin), 109 (1992) 12-19.
45. Purdy, R.H., Morrow, A.L., Moore Jr., P.H. and Paul, S.M., Stress-induced elevations of gamma-aminobutyric acid type-A active steroids in rat brain. Proc. Natl. Acad. Sci. USA, 88 (1991) 4553-4557.
46. Reddy, D.S. and Kulkarni, S.K., Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the antistress activity of neurosteroids in mice, Psychopharmacology, 128 (1996) (in press).
47. Robel, R. and Baulieu, E.E., Neurosteroids biosynthesis and function, Trends Endocrinol. Metab., 5 (1994) 1-8.
48. Rodriquez-Sierra, J.F., Howard, J.L., Pollard, G.T. and Hendricks, S.E., Effect of ovarian hormones on conflict behavior, Psychoneuroendocrinology, 9 (1984) 293-300.
49. Schlega, M.L., Spetz, L.F., Robel, P. and Haung, M., Studies on the effects of dehydroepiandrosterone and its metabolites on attack by castrated mice lactating intruders, Physiol. Behav., 34 (1985) 867-870.
50. Sherwin, B.B. and Gelfand, M.M., A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids, Obstet. Gynecol., 73 (1989) 759-766.
51. Smith, S.S., Waterhouse, B.D., Chapin, J.K. and Woodward, D.J., Progesterone alters GABA and glutamate responsiveness: a possible mechanism for its anxiolytic action, Brain Res., 400 (1987) 759-766.
52. Spence, K.T., Plata-Salaman, C.R. and Ffrench-Mullen, J.M.H., The neurosteroids pregnenolone and pregnenolone-sulfate but not progesterone, block calcium currents in acutely isolated hippocampal CA1 neurons, Life Sci., 49 (1991) 235-239.
53. Toubas, P.L., Abla, K.A., Cao, W., Logan, L.G. and Scale, T.W., Latency to enter a mirrored chamber: a novel behavioral assay for anxiolytic agents, Pharmacol. Biochem. Behav., 35 (1990) 121-126.
54. Wieland, S., Belluzzi, J.D., Stein, L. and Lan, N.C., Comparative behavioral characterization of the neuroactive steroids 3α-hydroxy-5β-pregnan-20-one and 3α-hydroxy,5β-pregnan-20-one in rodents, Psychopharmacology, 118 (1995) 65-71.
55. Wieland, S., Lan, N.C., Mirasedegi, S. and Gee, K.W., Anxiolytic activity of the progesterone metabolite 5α-hydroxy-pregnan-3α-ol-20-one, Brain Res., 565 (1991) 263-268.
56. Wu, F.S., Gibbs, T.T. and Farb, D.H., Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor, Mol. Pharmacol., 40 (1991) 333-336.
57. Wu, F.S., Gibbs, T.T. and Farb, D.H., Inverse modulation of gamma-aminobutyric acid and glycine-induced currents by progesterone, Mol. Pharmacol., 37 (1990) 597-602.